Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Should Step Up Funding For Rural Health Facilities, Medical Devices In New Five-Year Plan - EU Chamber Of Commerce In China

This article was originally published in PharmAsia News

Executive Summary

BEIJING - China's new Five Year Plan for economic and social development should be amended to provide greater support for upgrading rural hospitals, physician education, and decades-old medical equipment, according to an assessment of the guidelines by the European Union Chamber of Commerce in China

You may also be interested in...



Korea To Charge Patients More For Drugs Dispensed At Largest Hospitals

SEOUL - South Korea's Ministry of Health and Welfare is moving to charge patients more for drugs when they visit large general hospitals for minor ailments in an effort to deter public preference away from large hospitals, which has overburdened the country's national medical insurance system.

Korea To Charge Patients More For Drugs Dispensed At Largest Hospitals

SEOUL - South Korea's Ministry of Health and Welfare is moving to charge patients more for drugs when they visit large general hospitals for minor ailments in an effort to deter public preference away from large hospitals, which has overburdened the country's national medical insurance system.

Regulatory Revisions, Cut Backs At Big Pharma, Provide Spark For China Innovation - BayHelix Annual Meeting

SHANGHAI - BayHelix, a leading life sciences professional society for business leaders of Chinese origin, held its eighth annual conference in Shanghai April 10, and the day-long symposium trumpeted the opportunities for domestic pharma innovation brought on by China's healthcare reform and regulatory enhancements

Related Content

Latest News
See All
UsernamePublicRestriction

Register

SC077455

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel